M. Micksch, T. Strassner
FULL PAPER
elemental analyzer. 1-(4-Methoxyphenyl)imidazole (2),[82] 1-(4-ni-
trophenyl)imidazole (4),[82] 1-(2,4,6-trimethylphenyl)imidazole (5),
1-(2,6-diisopropylphenyl)imidazole (6),[82] imidazolium salts 8,[100]
10,[100] 12,[101] and complexes 13[81,102] 14,[81] 17,[83] 19,[83–85] and
20[86] were prepared according to literature procedures.
(5 mL) in an ACE pressure tube, CH2Br2 (0.3 mL, 4.0 mmol) was
added. A colorless precipitate formed after the solution had been
heated at 130 °C for 24 h. The precipitate was filtered and washed
with THF (3ϫ 5 mL). A colorless powder was obtained after the
1
product had been dried in vacuo (0.9 g, 72%). M.p. Ͼ 330 °C. H
NMR (300 MHz, [D6]DMSO, 25 °C): δ = 6.92 (s, 2 H, NCH2N),
7.60 (m, 4 H, ar), 7.91 (m, 4 H, ar), 8.42 (s, 4 H, ar), 10.35 (s, 2 H,
ar) ppm. 13C NMR (75 MHz, [D6]DMSO, 25 °C): δ = 58.3, 117.2,
121.9, 122.9, 124.7 (d, J = 9.5 Hz), 130.9 (d, J = 2.5 Hz), 137.5,
162.4 (d, J = 247.9 Hz) ppm. 19F NMR (282.4 MHz, [D6]DMSO,
25 °C): δ = –110.76 (d, J = 5.8 Hz) ppm. C19H16Br2F2N4 (495.17):
calcd. C 45.81, H 3.24, N 11.24; found C 45.45, H 2.97, N 11.46.
1-Phenylimidazole (1): Aniline (18.6 g, 0.2 mol) in MeOH (50 mL)
was treated with 30% aqueous glyoxal (32.4 mL, 0.2 mol) at room
temperature for 10 min to form a yellow mixture. NH4Cl (21.4 g,
0.4 mol) was added followed by 37% aqueous formaldehyde
(32 mL, 0.4 mol). The mixture was diluted with MeOH (400 mL)
and heated to reflux for 1 h before H3PO4 (28 mL, 85%) was slowly
added. The resulting mixture was then stirred at reflux for another
8 h. After removal of the solvent, the dark residue was poured onto
ice (300 g) and neutralized with 40% aqueous KOH solution until
the solution was at pH = 9. The resulting mixture was extracted
with dichloromethane (3ϫ 300 mL). The organic phases were com-
bined and dried (MgSO4). The solvent was removed, and after dis-
tillation a yellow oil was obtained (24.69 g, 86%). 1H NMR
(300 MHz, CDCl3, 25 °C): δ = 7.12 (s, 1 H, NCHN), 7.32 (m, 1 H,
3,3Ј-Bis(2,4,6-trimethylphenyl)-[(1,1Ј-diimidazolium)methane]
Di-
bromide (11): In comparison to the previously published synthe-
ses,[83,101] the change of the solvent from toluene or THF, respec-
tively, to acetonitrile led to a significant increase in the product
yield: To a solution of imidazole 5 (0.9 g, 5.0 mmol) in acetonitrile
(5 mL) in an ACE pressure tube, CH2Br2 (0.3 mL, 4.0 mmol) was
added. A colorless precipitate formed after the solution had been
heated at 130 °C for 24 h. The precipitate was filtered and washed
with cooled THF (3ϫ 5 mL). A colorless powder was obtained
after the product had been dried in vacuo (1.1 g, 81%). M.p. 307 °C
3
ar), 7.48 (m, 2 H, ar), 7.60 (d, JH,H = 8.5 Hz, 2 H, NCHCHN),
7.73 (s, 1 H, ar), 8.22 (s, 1 H, ar) ppm. 13C NMR (75 MHz, CDCl3,
25 °C): δ = 118.0, 120.3, 126.9, 129.1, 129.9, 135.6, 136.2 ppm.
C9H8N2 (144.18): calcd. C 74.98, H 5.59, N 19.43; found C 74.61,
H 5.70, N 19.51.
1
(dec.). H NMR (300 MHz, [D6]DMSO, 25 °C): δ = 2.05 (s, 12 H,
o-CH3), 2.35 (s, 6 H, p-CH3), 6.89 (s, 2 H, NCH2N), 7.19 (s, 4 H,
3
3
1-(4-Fluorophenyl)imidazole (3): 4-Fluoroaniline (11.1 g, 0.1 mol) in
MeOH (50 mL) was treated with 30% aqueous glyoxal (16.2 mL,
0.1 mol) at room temperature for 16 h to form a yellow mixture.
NH4Cl (10.7 g, 0.2 mol) was added followed by 37% aqueous form-
aldehyde (16 mL, 0.2 mol). The mixture was diluted with MeOH
(400 mL) and heated to reflux for 1 h. H3PO4 (14 mL, 85%) was
added slowly. The resulting mixture was then stirred at reflux for
another 8 h. After removal of the solvent, the dark residue was
poured onto ice (300 g) and neutralized with 40% aqueous KOH
solution until the solution was at pH = 9. The resulting mixture
was extracted with dichloromethane (3ϫ 300 mL). The organic
phases were combined and dried (MgSO4). The solvent was re-
moved, and the residue was subjected to sublimation in vacuo. Af-
ter purification by column chromatography on silica gel (ethyl acet-
ate), a white solid was obtained (12.1 g, 75%). M.p. 20 °C. 1H
NMR (300 MHz, CDCl3, 25 °C): δ = 7.11 (s, 1 H, ar), 7.18 (s, 1 H,
ar), 7.25 (m, 2 H, ar), 7.38 (m, 2 H, ar), 7.79 (s, 1 H, NCHN) ppm.
13C NMR (75 MHz, CDCl3, 25 °C): δ = 116.6 (d, J = 23.0 Hz),
118.5, 123.4 (d, J = 8.6 Hz), 130.5, 133.5 (d, J = 2.8 Hz), 135.7,
161.0 (d, J = 247.2 Hz) ppm. C9H7FN2 (162.17): calcd. C 66.66, H
4.35, N 17.27; found C 66.61, H 4.34, N 17.51.
ar), 8.10 (t, JH,H = 1.8 Hz, 2 H, NCHCHN), 8.38 (t, JH,H
=
3
1.8 Hz, 2 H, NCHCHN), 9.86 (d, JH,H = 1.4 Hz, 2 H, NCHN)
ppm. 13C NMR (75 MHz, [D6]DMSO, 25 °C): δ = 16.9, 20.6,
67.0, 122.8, 124.8, 129.4, 130.8, 134.2, 139.1, 140.6 ppm.
C25H30Br2N4·H2O (544.08): calcd. C 53.35, H 5.71, N 9.93; found
C 53.21, H 5.72, N 9.93.
3,3Ј-Bis(4-fluorphenyl)-[1,1Ј-diimidazolin-2,2Ј-diylidene)methane]-
palladium(II) Dibromide (15): A solution of Pd(OAc)2 (122 mg,
0.55 mmol) and bisimidazolium salt 9 (302 mg, 0.61 mmol) in
DMSO (10 mL) was heated at 60 °C for 2 h, 80 °C for 2 h, 100 °C
for 2 h, and 130 °C for 1 h. The solvent was removed under reduced
pressure, and the colorless residue was washed with methanol (2ϫ
5 mL) and acetonitrile (2 ϫ 5 mL) and dried in vacuo (267 mg,
1
81%). M.p. Ͼ 330 °C. H NMR (300 MHz, [D6]DMSO, 25 °C): δ
= 6.52 (m, 2 H, NCH2N), 7.51 (m, 4 H, NCHCHN), 7.81 (m, 8
H, ar) ppm. Owing to the low solubility of 15, no 13C NMR spectra
could be obtained. C19H14Br2F2N4Pd (602.55): calcd. C 37.87, H
2.34, N 9.30; found C 38.06, H 2.03, N 9.65.
3,3Ј-Bis(4-nitrophenyl)-[1,1Ј-diimidazolin-2,2Ј-diylidene)methane]-
palladium(II) Dibromide (16): A solution of Pd(OAc)2 (117 mg,
0.52 mmol) and bisimidazolium salt 10 (302 mg, 0.58 mmol) in
DMSO (10 mL) was heated at 60 °C for 2 h, 80 °C for 2 h, and
100 °C for 2 h. The solvent was removed under reduced pressure,
and the yellow residue was washed with methanol (2ϫ 5 mL) and
acetonitrile (2ϫ 5 mL) and dried in vacuo (300 mg, 88%). M.p.
Ͼ 330 °C. 1H NMR (300 MHz, [D6]DMSO, 25 °C): δ = 6.55 (m, 2
3,3Ј-Bisphenyl-[(1,1Ј-diimidazolium)methane] Dibromide (7): In
comparison with the previously published syntheses,[102] the change
of the solvent from toluene to acetonitrile led to a significant in-
crease of the product yield: To a solution of imidazole 1 (0.7 g,
5.0 mmol) in acetonitrile (5 mL) in an ACE pressure tube, CH2Br2
(0.3 mL, 4.0 mmol) was added. A colorless precipitate formed after
the solution had been heated at 110 °C for 24 h. The precipitate
was filtered and washed with THF (3ϫ 5 mL). A colorless powder
was obtained after the product had been dried in vacuo (0.6 g,
3
H, NCH2N), 7.93 (s, 4 H, NCHCHN), 8.14 (d, JH,H = 8.8 Hz, 4
H, ar), 8.58 (d, 3JH,H = 8.8 Hz, 4 H, ar) ppm. 13C NMR (75 MHz,
[D6]DMSO, 25 °C): δ = 63.4, 122.6, 122.8, 124.4, 126.5, 144.4
146.8, 160.2 ppm. C19H14Br2N6O4Pd (656.58): calcd. C 34.76, H
2.15, N 12.80; found C 34.65, H 1.76, N 13.04.
59%). M.p. 315 °C (dec.). 1H NMR (300 MHz, [D6]DMSO, 25 °C):
3
δ = 6.95 (s, 2 H, NCH2N), 7.67 (m, 6 H, ar), 7.84 (d, JH,H
=
3
7.4 Hz, 4 H, NCHCHN), 8.45 (dt, JH,H = 8.0, 1.6 Hz, 4 H,
NCHCHN), 10.41 (s, 2 H, NCHN) ppm. 13C NMR (75 MHz, [D6]-
DMSO, 25 °C): δ = 58.4, 121.6, 122.0, 123.1, 130.2, 130.0, 134.5,
137.4 ppm. C19H18Br2N4·0.5H2O (471.19): calcd. C 48.43, H 4.06,
N 11.89; found C 48.37, H 3.68, N 11.86.
(3,3Ј-Bis(2,6-diisopropylphenyl)-[1,1Ј-diimidazolin-2,2Ј-diylidene)-
methane]palladium(II) Dibromide (18): A solution of Pd(OAc)2
(177 mg, 0.79 mmol) and bisimidazolium salt 12 (551 mg,
0.87 mmol) in DMSO (14 mL) was heated at 60 °C for 3 h, 80 °C
for 3 h, and 110 °C for 2 h. The solvent was removed under reduced
pressure, and the colorless residue was washed with acetonitrile
(2ϫ 5 mL) and dried in vacuo (351 mg, 61%). M.p. 290 °C (dec.).
3,3Ј-Bis(4-fluorophenyl)-[(1,1Ј-diimidazolium)methane] Dibromide
(9): To a solution of imidazole 3 (0.8 g, 5.0 mmol) in acetonitrile
5878
www.eurjic.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2012, 5872–5880